Foghorn Therapeutics
FHTX
FHTX
62 hedge funds and large institutions have $226M invested in Foghorn Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.18% less ownership
Funds ownership: 63.36% → 63.18% (-0.18%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less capital invested
Capital invested by funds: $357M → $226M (-$132M)
Holders
62
Holding in Top 10
2
Calls
$651K
Puts
$1K
Top Buyers
| 1 | +$1.06M | |
| 2 | +$606K | |
| 3 | +$581K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$322K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$190K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$454K | |
| 3 | -$279K | |
| 4 |
BlackRock
New York
|
-$227K |
| 5 |
BC
Birchview Capital
Burlington,
Vermont
|
-$172K |